Tu-San-Qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China

Lin Zhu,Chun-yuan Zhang,Dong-ping Li,Hu-biao Chen,Jiang Ma,Hong Gao,Yang Ye,Ji-yao Wang,Peter P. Fu,Ge Lin
DOI: https://doi.org/10.1038/s41401-020-00553-9
IF: 7.169
2020-11-05
Acta Pharmacologica Sinica
Abstract:Herbs and dietary supplement-induced liver injury (HILI) is the leading cause of drug-induced liver injury in China. Among different hepatotoxic herbs, the pyrrolizidine alkaloid (PA)-producing herb <i>Gynura japonica</i> contributes significantly to HILI by inducing hepatic sinusoidal obstruction syndrome (HSOS), a liver disorder characterized by hepatomegaly, hyperbilirubinemia, and ascites. In China, <i>G. japonica</i> has been used as one of the plant species for Tu-San-Qi and is often misused with non-PA-producing Tu-San-Qi (<i>Sedum aizoon</i>) or even San-Qi (<i>Panax notoginseng</i>) for self-medication. It has been reported that over 50% of HSOS cases are caused by the intake of PA-producing <i>G. japonica</i>. In this review, we provide comprehensive information to distinguish these Tu-San-Qi-related herbal plant species in terms of plant/medicinal part morphologies, medicinal indications, and chemical profiles. Approximately 2156 Tu-San-Qi-associated HSOS cases reported in China from 1980 to 2019 are systematically reviewed in terms of their clinical manifestation, diagnostic workups, therapeutic interventions, and outcomes. In addition, based on the application of our developed mechanism-based biomarker of PA exposure, our clinical findings on the definitive diagnosis of 58 PA-producing Tu-San-Qi-induced HSOS patients are also elaborated. Therefore, this review article provides the first comprehensive report on 2214 PA-producing Tu-San-Qi (<i>G. japonica</i>)-induced HSOS cases in China, and the information presented will improve public awareness of the significant incidence of PA-producing Tu-San-Qi (<i>G. japonica</i>)-induced HSOS and facilitate future prevention and better clinical management of this severe HILI.
pharmacology & pharmacy,chemistry, multidisciplinary
What problem does this paper attempt to address?
The paper aims to address the following issues: 1. **Identification of Different Herbs**: The paper first compares three herbs related to "Tusanqi"—Panax notoginseng, Sedum aizoon, and Gynura japonica—in terms of plant morphology, distribution, medicinal effects, and chemical composition. This helps to distinguish these herbs and reduce misuse. 2. **Systematic Review of Case Reports**: The paper systematically reviews 2,156 cases of hepatic sinusoidal obstruction syndrome (HSOS) caused by the ingestion of Gynura japonica containing pyrrolizidine alkaloids (PA) reported in China from 1980 to 2019. These cases include detailed clinical manifestations, diagnostic methods, treatment interventions, and outcome analysis. 3. **Diagnostic and Treatment Methods**: The paper discusses the current methods used to diagnose PA-induced HSOS and provides treatment recommendations. Due to the lack of specific diagnostic tools, confirming the diagnosis remains challenging. Therefore, the paper emphasizes the importance of supportive and symptomatic treatment and explores treatment options such as anticoagulation therapy, transjugular intrahepatic portosystemic shunt (TIPS), and liver transplantation. 4. **Development of Mechanism-Based Biomarkers**: To assist in diagnosing HSOS caused by PA from Tusanqi, the paper develops a biomarker based on metabolic activation. By studying the metabolic process of PA and its N-oxides, the paper identifies the mechanisms leading to hepatotoxicity and proposes a new diagnostic method. In summary, this paper aims to raise public awareness of HSOS caused by PA from Gynura japonica and provide information and support for the prevention and better management of this severe drug-induced liver injury.